Vitamin D3 for Life

Live Enlightened

Physiology

Vitamin D in Early Tissue and Organ Development: Full Evidence Review

Previous related pageVitamin D in Early Tissue and Organ Development: Study SummaryNext related pageVitamin D in Early Tissue and Organ Development: Study Summary
Study at a glance

What was studied?

Does vitamin D affect how tissues and organs develop before and shortly after birth? The review compares studies of developing lungs, the pancreas and bones in people and animals.

What did the studies find?

Human and mouse lung studies found vitamin D related gene activity and selected protein changes. A rat study found pancreatic cell changes without clear impairment in overall blood sugar tests. A pregnancy trial found no clear overall benefit for newborn bone mineral content. Later findings from the same trial differed by the bone measurement used.

What does this mean?

Genes, proteins, cell numbers and organ function are different measurements. A change in one does not automatically show that an organ is damaged or that extra vitamin D improves human development.

What are the limits?

The studies examine selected tissues, not every organ. Animal findings do not establish effects in children. Some complementary studies were not fully assessed. Only the abstract of the 2026 bone follow-up was available, so its detailed results were not checked.

Read the full article below ↓

Vitamin D research asks several different questions about early development. A tissue may contain vitamin D related genes, change its activity when vitamin D availability changes, or develop a measurable structural or functional difference. Those observations are related, but they establish different things. This review examines selected lung, pancreatic and skeletal studies to explain what vitamin D signalling can contribute to the evidence about developing organs, and where conclusions about human development remain uncertain. For the shorter account, read Vitamin D in Early Tissue and Organ Development: Study Summary.

From a molecular signal to an organ outcome

Differentiation is the process through which developing cells acquire specialised characteristics. Organ development also requires cells to grow, organise into tissues and acquire functions. A change in a molecule involved in these processes does not necessarily mean that the final organ is smaller, damaged or unable to function. Conversely, an unchanged gross anatomical measurement does not rule out a more specific molecular or functional difference.

It therefore matters what investigators actually measured. Gene expression measures activity associated with particular genes. Protein measurements examine some of the products through which cells carry out their functions. Tissue measurements can examine cell numbers, arrangement or mineral content. Functional tests ask whether a system responds differently. None of these measures can automatically substitute for all the others. The distinction between a cell marker and a demonstrated change in identity is developed in Vitamin D, Cell Fate and Tissue Structure: Full Evidence Review.

The principal evidence considered here comprises four independent research programmes: developmental lung gene expression, experimental vitamin D deficiency in mouse lung development, maternal deficiency and pancreatic development in rats, and the MAVIDOS pregnancy trial of offspring bone health. These are not four interchangeable tests of one hypothesis. Together they allow comparison of molecular involvement, experimentally induced changes and a human developmental outcome. Later MAVIDOS publications remain part of the same trial.

The interventions described below are research protocols. A study dose cannot establish what an individual needs. For current UK infant and child guidance, see NHS Vitamins for children. Infants born early need advice from their neonatal team.

Developmental lung expression: evidence of involvement

Kho and colleagues examined vitamin D related genes in developing lungs and in datasets relevant to asthma. Their human developmental dataset included 38 fetal lungs from 53 to 154 days after conception. They also examined a mouse developmental time series and additional asthma-related datasets. The comparison identified enrichment of vitamin D related genes during lung development, with 38 genes shared between the relevant human and mouse developmental sets.

This finding places vitamin D related biology within a developmental setting. It makes it reasonable to investigate whether differences in vitamin D availability alter lung development. However, the study did not assign pregnant participants to vitamin D or placebo and then measure their children’s lungs. It examined patterns of gene expression. A gene’s appearance in a developmental pattern does not show that giving more vitamin D improves that process. For the receptor-level background to interpreting such signals, see Vitamin D Receptors.

Whole-lung samples also combine different cell populations. Expression can change because individual cells change their activity, because the proportions of cell types change, or because both occur. The selected gestational interval covers only part of development. Comparisons depend on the gene sets and statistical definitions used, and findings across species do not erase differences between human and mouse development.

This review uses the principal paper’s overall developmental expression finding. It does not make detailed claims about individual supplementary genes or heatmap patterns because those supplementary inventories were not fully inspected. The appropriate conclusion is biological involvement worthy of testing, rather than an established nutritional intervention for human lung formation. The biochemical background is explained in Vitamin D Activation; the specific enzymes involved in activation and breakdown are covered in Vitamin D Enzyme Pathways (CYP27B1 / CYP24A1). These processes provide context, not an additional measured developmental outcome in the expression study.

Experimental deficiency in developing mouse lungs

Chen and colleagues moved beyond expression mapping by comparing offspring of vitamin D deficient and sufficient mice. They examined female offspring at two prenatal stages and at seven days after birth. The protein analyses used six offspring per group at each prenatal stage and five per group after birth, with one offspring per litter. Sampling one offspring per litter helps avoid treating closely related littermates as completely independent observations.

The timing of the results was informative. The investigators identified 66 differing proteins at seven days after birth, but none meeting their criteria at the two prenatal stages. This is evidence that the detectable response depended on developmental stage and on the measurements available. It is not evidence that prenatal vitamin D had no biological relevance: small samples and the reach of the protein assay limit that inference.

Selected follow-up measurements gave the broad protein screen more specific meaning. Surfactant protein B was lower at seven days after birth, but not at the later prenatal stage. Surfactant proteins are relevant to the lung’s air-facing system, so this was a potentially functional developmental signal. A collagen measure was higher across the ages examined. One antioxidant-related protein result was supported at the postnatal stage, while two other selected protein findings were not confirmed by the validation measurements.

Those mixed validation results matter. A broad protein screen generates candidates, and the candidates do not all survive closer examination. Presenting only the confirmed changes would conceal part of the study’s uncertainty. Presenting every screened protein as an established mechanism would overstate what was tested.

The anatomical measurements did not show differences in gross lung volume, the proportion of airspaces or related structural measurements at the examined stages. Thus, molecular differences and unchanged gross structure occurred in the same experiment. This is a more precise result than either “vitamin D deficiency prevents lung development” or “vitamin D has no developmental effect.”

The study supports a stage-dependent molecular effect in female mice under the experimental conditions. It does not establish the size of any effect in human infants, a male offspring response, a later respiratory diagnosis or a supplement dose that prevents disease. Whole-lung measurements also leave the responsible cell populations incompletely resolved. The lung expression study and the mouse experiment complement one another, but neither converts the other into a human clinical trial.

Pancreatic development: cell phenotype and whole-body function

Schavinski and colleagues studied offspring of rats exposed to maternal vitamin D deficiency. The maternal diets began six weeks before conception and continued through pregnancy and lactation. Offspring received a standard diet after weaning and were assessed at 90 days. This exposure window combines conditions before birth with conditions during early feeding; it cannot identify a purely prenatal effect.

The experiment included control, deficient and deficient-with-mineral-rescue diets across 40 dams. The rescue diet changed calcium, phosphate and lactose together. Consequently, a comparison involving that group cannot isolate the effect of calcium alone. Individual outcome measurements generally involved five to eight offspring per group, and the extent to which litter relationships were accounted for was not clear enough to treat every offspring as an unquestionably independent replicate.

The pancreas contains islets, groups of cells involved in regulating blood glucose. Beta cells within these islets produce insulin. In male offspring, the investigators found lower fed-state insulin, reduced insulin secretion in selected isolated-islet tests, lower beta-cell mass and changes in selected gene expression. These are specific cellular and functional findings, not merely the detection of a receptor or a developmental gene.

Yet overall blood glucose regulation did not show a corresponding impairment in the reported glucose tolerance tests. A glucose tolerance test measures the body’s handling of a glucose challenge. Its result reflects more than the number or secretion behaviour of beta cells alone. The coexistence of altered islet measures and unchanged overall tests shows why a cellular phenotype should not be relabelled as established diabetes.

The sex pattern also requires care. Several effects were more evident in males, but females were not uniformly unaffected: total islet number was reduced in both sexes. A broad statement that deficiency affected only male offspring would therefore lose an important distinction between outcomes.

The investigators examined methylation of the promoter of Pdx1, a gene relevant to pancreatic identity and function. They did not find the proposed methylation difference. This negative result prevents the observed pancreatic phenotype from being described as proof of that particular epigenetic mechanism. Developmental effects can be observed while their molecular explanation remains unresolved. Vitamin D and Lasting Gene Regulation: Full Evidence Review examines the separate evidence needed to show that a gene-regulatory change persists after the original exposure changes.

Most of the male findings were not removed by the mineral-rescue diet. This result argues against assuming that this particular combined dietary rescue explained every outcome. It does not prove a uniquely vitamin D specific pathway, because the diets and the physiological responses are more complex than a single isolated variable. Nor does follow-up at 90 days establish lifelong persistence.

The study provides experimental evidence that the maternal and early postnatal nutritional environment can affect selected pancreatic features in rats. It does not show that maternal supplementation prevents human childhood diabetes. Its value for organ development is the separation of cell mass, secretion, gene regulation and whole-body glucose outcomes, rather than a clinical treatment conclusion.

A human developmental endpoint: neonatal bone mineral content

MAVIDOS provides a different kind of evidence. In this double-blind randomised trial, 1,134 pregnant women were allocated to vitamin D3 or placebo. The study regimen was 1,000 international units daily from approximately 14 to 17 weeks of pregnancy until delivery. Participants could also use a prenatal supplement containing up to 400 international units daily. These figures describe the experiment and are not individual dose recommendations.

The trial selected women with initial blood 25-hydroxyvitamin D concentrations between 25 and 100 nanomoles per litre. This blood measure is commonly used to describe vitamin D status. Vitamin D Testing: 25-OH-D vs 1,25-OH₂-D explains why it should not be confused with a measurement of the active hormone. The selection excluded severe deficiency as defined by the trial’s lower entry threshold, so the results should not be applied without qualification to that population. The participants were also predominantly White.

The principal newborn outcome was whole-body bone mineral content measured by a specialised X-ray scan. Although 737 newborns had some scan data, 665 contributed to this primary whole-body comparison: 338 in the vitamin D group and 327 in the placebo group. The difference between randomised participants and usable scans matters because movement and other practical factors can limit newborn measurements.

Mean whole-body bone mineral content was 61.6 grams in the supplemented group and 60.5 grams in the placebo group. The overall comparison was not statistically significant, with P = .21. This does not establish that the regimens were exactly equivalent, but it does not support an overall neonatal mineral-content benefit in the enrolled population.

A secondary winter-birth analysis favoured supplementation by 5.5 grams, with a 95% confidence interval from 1.8 to 9.1 grams. The season interaction had P = .04. However, the trial examined ten interactions without adjustment for multiple comparisons. This seasonal result is therefore a qualified finding, not a confirmed rule that a particular pregnancy dose improves every winter-born infant’s skeleton.

Bone mineral content describes mineral accumulated in the measured skeleton. It does not directly measure embryonic cell differentiation, future fractures or every aspect of bone quality. Bone Mineralisation, Turnover and Fractures Measure Different Outcomes develops this distinction between skeletal measurements. MAVIDOS supplies a human late-fetal skeletal outcome against which broad claims about organ benefit can be checked. It should not be presented as a direct experiment on early embryonic lineages.

Later findings also prevent the neonatal result from being treated as the final answer about all skeletal outcomes. A 2024 follow-up of the same trial reported modestly higher childhood bone-density measures in the supplemented group. That analysis involved selected follow-up participants and was exploratory. A 2026 MAVIDOS paper’s abstract reported no detected difference in tibial microarchitecture or volumetric density. The full 2026 paper and its supplementary material were not available for this review, so its detailed methods, estimates and robustness were not assessed. These are different measurements and ages within one trial, not independent confirmations or a simple uniform benefit.

What the selected tissues establish together

Across these studies, the strongest common finding is that developmental stage and the level of measurement change the answer. Developing lungs show vitamin D related expression patterns; experimental deficiency changes selected postnatal lung proteins without a demonstrated gross structural difference. Rat pancreatic findings include altered cell and secretion measures alongside unchanged whole-body glucose tests. A human pregnancy trial did not find an overall neonatal mineral-content benefit, although later skeletal measures and subgroup findings were not uniformly null.

These differences are scientifically useful. They show why receptor-related activity, tissue differentiation, organ anatomy and later disease must remain separate parts of the explanation. Experimental manipulation strengthens causal interpretation within an animal model. Random allocation strengthens interpretation of the particular human regimen and outcomes tested. Neither design supports every other developmental claim.

This is a selected cross-tissue review, not a complete survey of all developing organs. Relevant human fetal pancreatic culture research and animal and human kidney studies were identified but were not fully appraised here. The absence of a detailed discussion of those studies must not be read as evidence that the work does not exist, or that vitamin D has no relationship with those tissues. It limits the breadth of the present conclusions.

The evidence supports further investigation of tissue-specific and stage-specific vitamin D biology. It does not establish that increasing vitamin D exposure uniformly improves organ development, that a molecular difference is necessarily harmful, or that every fetal organ requires direct vitamin D signalling in the same way. Those larger claims would require broader, directly assessed evidence and appropriate human functional outcomes.

Scientific sources

Kho AT and colleagues. Vitamin D related genes in lung development and asthma pathogenesis. BMC Medical Genomics. 2013;6:47. DOI: 10.1186/1755-8794-6-47. Principal paper assessed; supplementary gene inventories not fully inspected.

Chen L, Wilson R, Bennett E, Zosky GR. Identification of vitamin D sensitive pathways during lung development. Respiratory Research. 2016;17:47. DOI: 10.1186/s12931-016-0362-3.

Schavinski AZ and colleagues. Maternal Vitamin D Deficiency Impairs the Development of β Cells in Offspring Rats in a Sex-Dependent Manner. International Journal of Molecular Sciences. 2024;25:4136. DOI: 10.3390/ijms25084136.

Cooper C and colleagues. Maternal gestational vitamin D supplementation and offspring bone health (MAVIDOS): a multicentre, double-blind, randomised placebo-controlled trial. The Lancet Diabetes & Endocrinology. 2016;4:393 to 402. DOI: 10.1016/S2213-8587(16)00044-9. Principal paper and material supplement assessed.

Moon RJ and colleagues. Pregnancy vitamin D supplementation and offspring bone mineral density in childhood follow-up of a randomized controlled trial. The American Journal of Clinical Nutrition. 2024;120:1134 to 1142. DOI: 10.1016/j.ajcnut.2024.09.014. Same MAVIDOS trial; principal paper and material supplementary tables assessed.

Maden C and colleagues. Vitamin D supplementation during pregnancy and offspring bone microarchitecture: A post hoc analysis of the MAVIDOS randomised controlled trial. Bone. 2026;207:117843. DOI: 10.1016/j.bone.2026.117843. Abstract only; full paper and supplements not assessed.

Ng and colleagues. Vitamin D and vitamin A receptor expression and the proliferative effects of ligand activation of these receptors on the development of pancreatic progenitor cells derived from human fetal pancreas. Stem Cell Reviews and Reports. 2010. DOI: 10.1007/s12015-010-9146-1. Identified complementary research; principal paper not assessed.

Maka and colleagues. Vitamin D deficiency during pregnancy and lactation stimulates nephrogenesis in rat offspring. Pediatric Nephrology. 2008. DOI: 10.1007/s00467-007-0641-9. Identified complementary research; principal paper not assessed.

Vitamin D status during fetal life and childhood kidney outcomes. European Journal of Clinical Nutrition. 2016. DOI: 10.1038/ejcn.2015.216. Generation R cohort; identified complementary research, full paper available but not appraised for this review.

Related reading

Original sources

Source

Vitamins for children

The interventions described below are research protocols.

Publication details

The interventions described below are research protocols. A study dose cannot establish what an individual needs. For current UK infant and child guidance, see NHS Vitamins for children. Infants born early need advice from their neonatal team.

Read more →
Source

Vitamin D related genes in lung development and asthma pathogenesis

Poor maternal vitamin D intake is a risk factor for subsequent childhood asthma, suggesting that in utero changes related to vitamin D responsive genes might play a crucial role in later disease susceptibility.

Publication details

Kho AT and colleagues. Vitamin D related genes in lung development and asthma pathogenesis. BMC Medical Genomics. 2013;6:47. DOI: 10.1186/1755-8794-6-47. Principal paper assessed; supplementary gene inventories not fully inspected.

Read more →
Source

Identification of vitamin D sensitive pathways during lung development

In this study, we aimed to identify the mechanisms linking vitamin D with lung development using a mouse model of dietary manipulation.

Publication details

Chen L, Wilson R, Bennett E, Zosky GR. Identification of vitamin D sensitive pathways during lung development. Respiratory Research. 2016;17:47. DOI: 10.1186/s12931-016-0362-3.

Read more →
Source

Maternal gestational vitamin D supplementation and offspring bone health (MAVIDOS): a multicentre, double-blind, randomised placebo-controlled trial

Published in The Lancet Diabetes & Endocrinology (2016).

Publication details

Cooper C and colleagues. Maternal gestational vitamin D supplementation and offspring bone health (MAVIDOS): a multicentre, double-blind, randomised placebo-controlled trial. The Lancet Diabetes & Endocrinology. 2016;4:393 to 402. DOI: 10.1016/S2213-8587(16)00044-9. Principal paper and material supplement assessed.

Read more →
Source

Pregnancy vitamin D supplementation and offspring bone mineral density in childhood follow-up of a randomized controlled trial

Published in The American Journal of Clinical Nutrition (2024).

Publication details

Moon RJ and colleagues. Pregnancy vitamin D supplementation and offspring bone mineral density in childhood follow-up of a randomized controlled trial. The American Journal of Clinical Nutrition. 2024;120:1134 to 1142. DOI: 10.1016/j.ajcnut.2024.09.014. Same MAVIDOS trial; principal paper and material supplementary tables assessed.

Read more →
Source

Vitamin D supplementation during pregnancy and offspring bone microarchitecture: A post hoc analysis of the MAVIDOS randomised controlled trial

Published in Bone. 2026;207:117843. DOI: 10.1016/j.bone (2026).

Publication details

Maden C and colleagues. Vitamin D supplementation during pregnancy and offspring bone microarchitecture: A post hoc analysis of the MAVIDOS randomised controlled trial. Bone. 2026;207:117843. DOI: 10.1016/j.bone.2026.117843. Abstract only; full paper and supplements not assessed.

Read more →
Source

Vitamin D and vitamin A receptor expression and the proliferative effects of ligand activation of these receptors on the development of pancreatic progenitor cells derived from human fetal pancreas

Published in Stem Cell Reviews and Reports (2010).

Publication details

Ng and colleagues. Vitamin D and vitamin A receptor expression and the proliferative effects of ligand activation of these receptors on the development of pancreatic progenitor cells derived from human fetal pancreas. Stem Cell Reviews and Reports. 2010. DOI: 10.1007/s12015-010-9146-1. Identified complementary research; principal paper not assessed.

Read more →
Source

Vitamin D status during fetal life and childhood kidney outcomes

Published in European Journal of Clinical Nutrition (2016).

Publication details

Vitamin D status during fetal life and childhood kidney outcomes. European Journal of Clinical Nutrition. 2016. DOI: 10.1038/ejcn.2015.216. Generation R cohort; identified complementary research, full paper available but not appraised for this review.

Read more →